Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro 10mg injection is the fourth rung in tirzepatide's six-step dose schedule, typically reached after around three months of treatment. By this point most people have moved through the 2.5mg, 5mg and 7.5mg strengths. Mounjaro 10mg is a prescription-only medicine prescribed only after a clinical assessment confirms it is the right next step for you — your prescriber decides, based on how you have responded so far.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is not started at 10mg. The schedule exists for a reason: each lower dose lets your body adjust to the medicine before the next increase. Most people begin at 2.5mg for four weeks, then move to 5mg, then 7.5mg, with the prescriber confirming each step is appropriate. The full Mounjaro dose schedule is set out by Eli Lilly in the Summary of Product Characteristics and is not something a patient adjusts independently.
What brings you to 10mg, practically speaking, is four weeks at 7.5mg without side effects that make a further increase inadvisable. Your prescriber (at nume, a GPhC-registered Independent Prescriber who reads your update personally) signs off the step. No algorithm does that. If you are transferring from another provider already established on 10mg, you will be asked to provide evidence of your current dose before a Mounjaro injection 10mg prescription is issued.
A quick habit worth building: before any new pen, glance at the label. The strength is printed clearly. It takes about ten seconds and catches mix-ups before they happen, useful at any dose, especially when stepping up.
Mounjaro works by activating both the GIP and GLP-1 receptors involved in appetite regulation and blood-sugar signalling) the only licensed weight-management medicine in the UK to target both pathways. At 10mg, that dual action is operating at a meaningfully higher level than at 7.5mg. Many people notice a more consistent reduction in appetite between doses and a stronger sense of fullness after smaller portions.
The clinical trial programme showed progressively greater average weight loss at higher doses. In SURMOUNT-1, published in the New England Journal of Medicine, participants on the highest dose (15mg) achieved around 20–21% average body-weight reduction over 72 weeks. The data for 10mg sit between those for 7.5mg and 12.5mg, your prescriber can discuss what that means for your individual plan. Results vary; a clinical trial average is not a personal prediction.
For more context on how the doses compare across the full range, the Mounjaro overview sets out the licensed schedule alongside eligibility information.
GI side effects) nausea, loose stools, constipation, indigestion, burping, are the most commonly reported reactions to tirzepatide and tend to be most noticeable in the days after a dose increase. Moving to 10mg is a step-up, so some temporary worsening is possible. For most people it settles within a week or two as the body adapts.
Practical strategies that prescribers commonly discuss include eating more slowly, keeping portions modest, avoiding high-fat meals, and staying well hydrated. None of these replace individual advice: if side effects at 10mg are persistent or severe, the right move is to contact your prescriber or our aftercare team rather than self-adjust the timing or dose.
The NHS medicines information page for tirzepatide lists the full side-effect profile and explains when to seek urgent medical attention. One signal worth knowing: severe, persistent stomach pain that extends towards the back warrants prompt medical assessment, given the MHRA's 2026 Drug Safety Update on acute pancreatitis and GLP-1 medicines. Report any suspected side effects via the MHRA Yellow Card scheme.
If 10mg is working well and is tolerated, the licensed schedule allows a further step to 12.5mg after four weeks, and then to 15mg. Not everyone needs or reaches the top dose, some people find 10mg is where appetite suppression stabilises and further titration adds little. That is a conversation with your prescriber, not a decision to make in isolation.
If you are curious about how 10mg sits relative to the step above it, the 5mg page and its siblings cover the earlier doses in the same detail. For a broader view of what the full schedule involves across the programme, our dose guidance page is the place to start.
Treatment at 10mg, like every Mounjaro prescription from nume, comes with access to prescriber-led aftercare seven days a week. Every repeat order goes through a fresh clinical review, not a checkbox, a read. If you are not yet on treatment and want to understand whether Mounjaro is clinically suitable for you, the free consultation is the first step. Private treatment has no waiting list and is subject only to clinical suitability; it is not available without a prescription following that assessment.
For a sense of what treatment costs at this stage of the schedule, the Mounjaro pricing page explains what is included in one transparent price, consultation, prescription, delivery and aftercare.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.